Latest Convertible Securities News

InFocus Group Holdings has launched Codexa, a proprietary sweepstakes casino platform targeting the US market, and secured an expanded contract for its Prodigy9 subsidiary in Thailand, while navigating cash flow pressures amid ongoing R&D investment.

Brazilian Critical Minerals (ASX: BCM) has reinforced the scale and quality of its Ema rare earth project with strong drilling results and steady progress on permitting and feasibility studies, positioning it well amid tightening global supply.

Latitude Group Holdings Limited has launched an offer to raise approximately $100 million through Capital Notes 2, a new series of perpetual, subordinated, unsecured convertible notes. Existing Capital Notes 1 holders are invited to reinvest in the new notes, which feature discretionary quarterly distributions and potential conversion to ordinary shares.

Imugene Limited has launched a $20 million equity raising comprising a $12 million placement and an $8 million Share Purchase Plan, alongside issuing options, convertible notes, and warrants to support its azer-cel clinical program.

Cann Group Limited has raised $750,000 through a convertible note agreement with Obsidian Global, aiming to strengthen its working capital and move towards EBITDA positivity.

Macquarie Technology Group has landed a significant A$200 million hybrid capital injection from the Australian Government-backed National Reconstruction Fund Corporation, aimed at boosting sovereign digital infrastructure and cybersecurity services.

Argent BioPharma reported a significantly reduced half-year loss of A$2.9 million, progressing a strategic acquisition to bolster its CannEpil drug pipeline and securing up to A$11 million in new funding.

MinRex Resources Limited (ASX: MRR) has announced a definitive agreement to acquire 100% of Electrum Discovery Corp. (TSX-V: ELY) via a statutory Plan of Arrangement, creating a combined ASX-listed gold-copper exploration company with significant assets in Serbia and Australia.

Native Mineral Resources reported steady gold production at its Blackjack operations, completed key plant upgrades, and progressed joint ventures, supported by a $3 million convertible note raise.

Argent BioPharma has restructured its acquisition of AusCann assets to sharpen its clinical focus and secured a substantial A$11 million financing facility, positioning itself for growth in 2026.

Resource Minerals International Ltd reports standout gold and silver assay results from Saudi projects alongside a $1 million capital raise, setting the stage for intensified drilling campaigns in 2026.

Global Uranium and Enrichment Limited has finalised the share and option scheme considerations for its acquisition by Snow Lake Resources, with directors backing the deal ahead of the upcoming shareholder vote.